PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 138.00
+1.00 (0.72%)
Jul 16, 2025, 3:32 PM WIB
IDX:LABS Revenue
PT UBC Medical Indonesia Tbk had revenue of 33.46B IDR in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 152.36B. In the year 2024, PT UBC Medical Indonesia Tbk had annual revenue of 147.64B with 8.00% growth.
Revenue (ttm)
152.36B
Revenue Growth
+8.00%
P/S Ratio
3.58
Revenue / Employee
2.46B
Employees
62
Market Cap
545.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition